Cargando…
Influence of probenecid on endoxifen systemic exposure in breast cancer patients on adjuvant tamoxifen treatment
INTRODUCTION: In breast cancer patients treated with the anti-estrogen tamoxifen, low concentrations of the active metabolite endoxifen are associated with more disease recurrence. We hypothesized that we could increase endoxifen concentrations by induction of its formation and inhibition of its met...
Autores principales: | Buck, Stefan A. J., Braal, C. Louwrens, Hofman, Maaike M., Oomen-de Hoop, Esther, de Bruijn, Peter, Ghobadi Moghaddam-Helmantel, Inge M., Hussaarts, Koen G. A. M., Vastbinder, Mijntje B., van Rossum-Schornagel, Quirine C., van Schaik, Ron H. N., Jager, Agnes, Koolen, Stijn L. W., Mathijssen, Ron H. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935557/ https://www.ncbi.nlm.nih.gov/pubmed/35321309 http://dx.doi.org/10.1177/17588359221081075 |
Ejemplares similares
-
Therapeutic Drug Monitoring of Endoxifen for Tamoxifen Precision Dosing: Feasible in Patients with Hormone-Sensitive Breast Cancer
por: Braal, C. Louwrens, et al.
Publicado: (2021) -
Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen
por: Braal, C. Louwrens, et al.
Publicado: (2020) -
The impact of endoxifen-guided tamoxifen dose reductions on endocrine side-effects in patients with primary breast cancer
por: Buijs, S.M., et al.
Publicado: (2023) -
Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen
por: Hussaarts, Koen G.A.M., et al.
Publicado: (2019) -
Factors affecting inter-individual variability in endoxifen concentrations in patients with breast cancer: results from the prospective TOTAM trial
por: Braal, C. Louwrens, et al.
Publicado: (2022)